Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.

Vanda Pharmaceuticals’ expansion into the booming GLP-1 market has cleared a midphase test. | Vanda Pharmaceuticals’ ...

Novo Nordisk plans “all in” launch of Wegovy pill in the US market and will cut price of the drug's injectable option in the ...

For a limited time, patients in the US can get the first two doses of authentic, FDA-approved Wegovy(R) and Ozempic(R) for only $199 each beginning November 17, 2025 -- Also effective November 17, ...

Why Am I Not Losing Weight on Wegovy®? How to Get Results Key takeaways: Not losing weight on Wegovy® could be due to dose, ...

Until the end of March, Novo Nordisk will let people with prescriptions buy the first two doses of the drugs for $199 a month ...

For a limited time, patients with a prescription can get a steep discount on the popular medications, as long as they’re ...

Vanda Pharmaceuticals' tradipitant successfully reduced Wegovy-induced vomiting by 50% in a clinical trial. Phase 3 ...

This article was reviewed by Darragh O’Carroll, MD. How Much Does Wegovy® Cost With and Without Insurance? Key takeaways: ...

Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on its upcoming oral weight-loss pill, as the firm races to claw back lost ...